BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:This year SAE's 3rd annual Oligonucleotide Therapeutics and De
 livery conference will showcase recent advances in oligonucleotide develo
 pment\, regulatory requirements and CMC considerations\, strategies to en
 hance oligonucleotide discovery and targeting and optimised delivery tech
 niques for oligonucleotide-based therapies\, in the hope to continue to d
 rive forward the field of oligonucleotide drug development. Join us on th
 e 11-12 September.\n\nThe only event that will:\n\nShowcase new represent
 ation and insights from the following big pharma companies\, with a high 
 level agenda focussing on driving industry advancement\, whilst also offe
 ring benchmarking and networking opportunities for leading figures in the
  industry.• Eli lilly• Moderna• BioNTech• Alnylam Pharmaceuticals• GSK• M
 erck• Servier• AstraZeneca• Roche• Bayer\n\nWhat's different this year:\n
 \nThis year the conference will be chaired by two leaders in the field of
  oligonucleotide therapeutics and delivery: Joseph R. Martinelli\, Execut
 ive Director\, Genetic Medicine\, Eli Lilly and Company and Edward Hennes
 sy\, Senior Director\, Discovery Chemistry\, Moderna.\n\nTime: 9:00 am - 
 5:00 pm\n
DTEND:20230912T170000
DTSTAMP:20260512T214259Z
DTSTART:20230911T090000
LOCATION:Hilton London Kensington\, 179-199 Holland Park Avenue\, London\,
  England\, W11 4UL\,
SEQUENCE:0
SUMMARY:This year SAE's 3rd annual Oligonucleotide Therapeutics and Delive
 ry conference will showcase recent advances in oligonucleotide developmen
 t\, regul...
UID:cd0a45da-c3bb-44ce-b4c4-787e4d830f76
END:VEVENT
END:VCALENDAR